Delivery Order SPE2DB24D2102-SPE2DB25FJJQE
- Not listed
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $15,614.63 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract, executed on August 25, 2025, with completion scheduled for August 26, 2025, operates under firm fixed pricing with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,925.06 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, under a firm fixed-price contract type with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $4,929.08 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. Issued on August 25, 2025, with an ultimate completion date of August 26, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,065.95 for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, carries a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order from...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,703.75 delivery order for 60 tablets of Eliquis 5 mg, a widely-used anticoagulant medication. This firm fixed-price delivery order, issued on August 15, 2025, with completion scheduled for August 18, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was awarded competitively with no...
- The Defense Logistics Agency awarded a delivery order valued at $2,705.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The award, issued on July 24, 2025, with completion targeted for July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $15,235.54 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order, awarded on July 28, 2025, with a completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement executed against an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $9,868.31 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This competitive delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, carries firm fixed pricing and represents a child contract under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,343.62 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitively awarded, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order...
- SPE2DB24D2102Indefinite Delivery Contract
- SPE2DB24D2102-SPE2DB25FJJQEDelivery Order
The Defense Logistics Agency awarded a $23,088.53 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The contract, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare systems worldwide. AmerisourceBergen's federal contract portfolio demonstrates its critical role as a major pharmaceutical distributor for Defense Health Agency and other federal healthcare customers, with consistent competitively awarded contracts spanning multiple therapeutic categories and delivery formats.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.1k | 8/25/25 |